Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients

References

Page 1

	Year	Citations
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer Joan H. Schiller, David Harrington, Chandra P. Belani, New England Journal of Medicine	2002	4.9K
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER J Oan H. S Chiller, D Avid H Arrington, C Handra P. B Elani, Median SurvivalMedicineCancer ManagementPharmacologyToreceive Cisplatin	2002	3.7K
The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer Valerie W. Rusch, Hisao Asamura, Hirokazu Watanabe, Journal of Thoracic Oncology Forthcoming Seventh EditionCancer DetectionMedicinePathologyRadiomics	2009	1.2K
PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer Luis Paz‐Ares, Filippo de Marinis, Mircea Dediu, Journal of Clinical Oncology	2013	627
Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study Michael T. Milano, Alan W. Katz, Hong Zhang, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineLong-term Follow-upRadiation TherapyRadiopharmaceutical TherapyHead And Neck Surgery	2011	439
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial David A. Palma, Cornelis J.A. Haasbeek, George Rodrigues, BMC Cancer	2012	306
Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450) Dirk De Ruysscher, Rinus Wanders, Angela van Baardwijk, Journal of Thoracic Oncology OncologySynchronous OligometastasesPharmacologyClinical TrialsBronchial Neoplasm	2012	278
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): Patient outcomes and prognostic factors Gwendolyn H.M.J. Griffioen, Daniel Toguri, Max Dahele, Lung Cancer Prognostic FactorsRadical TreatmentMedicinePatient OutcomesBronchial Neoplasm	2013	156
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival Tessa de Vin, Benedikt Engels, Thierry Gevaert, Annals of Oncology	2013	104
Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer Michael D. Hasselle, Daniel J. Haraf, Kyle E. Rusthoven, Journal of Thoracic Oncology Adaptive RadiotherapyImage-guided Radiation TherapyMedical ImagingRadiation TherapyMedicine	2011	100

Page 1